Mammography
This article was originally published in The Gray Sheet
Executive Summary
Digital mammography reimbursement would equal 150% of the amount that would otherwise be paid for bilateral diagnostic mammography under a Feb. 1 HCFA program memo to implement BIPA. For technologies that convert standard film images to digital form, payment will be derived from the statutory screening mammography limit plus an additional $15. The BIPA legislation provides for new payment methodologies for both diagnostic and screening mammograms that utilize advanced technology for the period April 1 to Dec. 31
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.